Patent Application
Utility
App. No. 16/548,682
· Confirmation No. 6941
CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
Applicant:
Endo Pharmaceuticals Solutions Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-02-05 | ABN |
Abandonment | 2 | View | |
| 2020-07-29 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-07-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-07-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-07-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-07-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-07-21 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-04-30 | N/AP |
Notice of Appeal Filed | 2 | View | |
| 2020-04-30 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-04-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-02-13 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2019-12-31 | CTFR |
Final Rejection | 11 | View | |
| 2019-12-31 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2019-12-31 | 1449 |
List of References cited by applicant and considered by examiner | 20 | View | |
| 2019-12-31 | 1449 |
List of References cited by applicant and considered by examiner | 20 | View | |
| 2019-12-31 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2019-11-07 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-11-07 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2019-11-07 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-11-04 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-11-04 | DRW |
Drawings-only black and white line drawings | 12 | View | |
| 2019-11-04 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2019-11-04 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2019-09-24 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 20 | View | |
| 2019-09-24 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2019-09-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-09-24 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2019-09-05 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-09-05 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2019-09-05 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2019-09-05 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-08-22 | PA.. |
Power of Attorney | 2 | View | |
| 2019-08-22 | DRW |
Drawings-only black and white line drawings | 12 | View | |
| 2019-08-22 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-08-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-08-22 | ADS |
Application Data Sheet | 9 | View | |
| 2019-08-22 | SPEC |
Specification | 41 | View | |
| 2019-08-22 | CLM |
Claims | 3 | View | |
| 2019-08-22 | ABST |
Abstract | 1 | View | |
| 2019-08-22 | A.PE |
Preliminary Amendment | 1 | View | |
| 2019-08-22 | SPEC |
Specification | 1 | View | |
| 2019-08-22 | CLM |
Claims | 2 | View | |
| 2019-08-22 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View |
Inventors
Petr Kuzma
Princeton, NJ
Stefanie Decker
Princeton, NJ
Attorneys & Agents of Record
Classification
USPC
514/16
A61K9/0024
A61K38/31
A61P5/50
A61P5/08
A61P9/00
A61P3/10
A61P9/12
A61P5/00
A61P5/06
A61P1/04
A61P5/12
A61P35/00
A61K47/12
A61K47/32
A61K47/34
A61K47/38
Prosecution
- Examiner
- REYNOLDS, FRED H
- Art Unit
- 1658
- Customer No.
- 105159
- Docket No.
- EPSI-107US5
- Confirmation No.
- 6941
Publication
- Pub. No.
- US20200046806A1
- Pub. Date
- 2020-02-13
Parent
is a Continuation of
→
App. 15/246,020
Filed 2016-08-24
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 12/814,276
Filed 2010-06-11
· Abandoned -- After Examiner's Answer or Board of Appeals Decision
Parent
is a Continuation of
→
App. 12/240,690
· US 7,803,773
Filed 2008-09-29
· Patented Case
Parent
is a Continuation of
→
App. 11/372,749
· US 7,452,868
Filed 2006-03-10
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/660,930
Filed 2005-03-11
· Provisional Application Expired
Child
is a Continuation of
→
App. 16/942,309
Filed 2020-07-29
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 18/124,237
Filed 2023-03-21
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 19/017,114
Filed 2025-01-10
· Docketed New Case - Ready for Examination
Child
is a Continuation of
→
App. 17/676,496
Filed 2022-02-21
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/422,859
Filed 2024-01-25
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/496,361
Filed 2021-10-07
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/230,990
Filed 2023-08-07
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/183,925
Filed 2021-02-24
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/847,839
Filed 2022-06-23
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/981,752
Filed 2022-11-07
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/784,242
Filed 2024-07-25
· Abandoned -- Incomplete Application (Pre-examination)
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH HOLDINGS, LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.),
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-26
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR PHARMACEUTICAL COMPANIES, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-25
from
ASTORA WOMEN'S HEALTH LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-09-17
from
ASTORA WOMEN'S HEALTH LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2020-05-26
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/548,682
- Filed
- 2019-08-22
- Pub. No.
- US20200046806A1
- Examiner
- REYNOLDS, FRED H
- Art Unit
- 1658
External Links